Mutations in the coding region of FOXP2 are known to cause speech and language impairment. Microdeletions involving the region downstream the gene have been also associated to speech and cognitive deficits. We recently described a girl harbouring a complex chromosomal rearrangement with one breakpoint downstream the gene that might affect her speech and cognitive abilities via physical separation of distant regulatory DNA elements. In this study, we have used highly efficient targeted chromosomal deletions induced by the CRISPR/Cas9 genome editing tool to demonstrate the functionality of two enhancers, FOXP2-E proximal and FOXP2-E distal , located in the intergenic region between FOXP2 and its adjacent MDFIC gene. Deletion of any of these two functional enhancers in the neuroblastomic cell line SK-N-MC downregulates FOXP2 and decreases FOXP2 protein levels, conversely it upregulates MDFIC and increases MDFIC protein levels. This suggests that both regulatory elements may be shared between FOXP2 and MDFIC. We expect these findings contribute to a deeper understanding of how FOXP2 and MDFIC are regulated to pace neuronal development supporting speech and language.
INTRODUCTION
Mutations in the gene FOXP2, encoding a transcription factor, are known to cause speech and language impairment (Vargha-Khadem et al. 2005; Zhao et al. 2010) . Polymorphisms of the gene have been also associated to schizophrenia (Tolosa et al. 2010 ) and frontotemporal lobar degeneration (Padovani et al. 2010 ). FOXP2 has been hypothesised to regulate the development and function of brain areas involved in human language processing (Lai et al., 2003; Fisher and Scharff 2009) , because of its known role in neurogenesis, neuron differentiation and migration patterns in the developing telencephalon in mice (Tsui et al. 2013; Chiu et al. 2014; Garcia-Calero et al. 2016) . Pathogenic mutations in humans have proven to impair auditory-motor association learning in mice (Kurt et al. 2012) . Nonetheless, the exact role of FOXP2 in normal development is unknown. Common variants of the gene do not contribute appreciably to individual differences in language development (Mueller et al. 2016) , nor in brain structure (Hoogman et al. 2014) , although a FOXP2 polymorphism has been associated with enhanced procedural learning of nonnative speech sound categories (Chandrasekaran et al. 2015) . Less is known about how the expression of the gene is modulated. The promoter of FOXP2 contains four transcription start sites (Schroeder and Myers 2008) , with multiple alternative splicing sites (Bruce and Margolis 2002) . FOXP2 also contains six ultraconserved regions in its introns (Bejerano et al. 2004, Schroeder and Myers 2008) , as well as six predicted enhancers for Lef1 (Hallikas et al 2006) . Lef1 is a transcription factor that drives expression of the Foxp2 gene in the central nervous system during zebrafish embryogenesis (Bonkowsky et al. 2008 ).
Interestingly, several microRNAS bind the 3'UTR of the gene and regulate the expression of FOXP2 (Clovis et al. 2012; Shi et al. 2013; Fu et al. 2014a; Cuiffo et al. 2014) .
Apart from gene mutations, microdeletions involving FOXP2 and/or MDFIC, the adjacent gene downstream FOXP2, and the region between these two genes have been found in subjects with speech delay and cognitive impairment (DECIPHER patients 262086, 292652, and 301696) . We have recently reported on a young female harbouring a genomic complex rearrangement involving chromosomes 7 and 11, who presents with severe expressive and receptive speech and language impairment in both Castilian Spanish and Valencian (Moralli et al. 2015) . Although the FOXP2 coding region is intact, the breakpoint in 7q31.1 is located 205.5 kb downstream the 3' end of FOXP2 and 22.8 kb upstream the 5' region of MDFIC. Becker et al. (2015) found and characterized a functional enhancer located 2.5 kb downstream the breakpoint and hypothesized that rearrangement of this enhancer by chromosomal translocation may contribute to the observed language phenotype by disturbing FOXP2 gene expression. In our proband this element was hypothesized to be in derivative chromosome 7q separated from FOXP2. While FOXP2 was shown to have been rearranged to derivative chromosome 11p, MDFIC had been located in derivative chromosome 7q, based on the FISH results from the RP11-243D16 BAC (Moralli et al 2015) . A more robust approach, aimed at looking for changes in the expression levels of the gene seems desirable in order to know if this enhancer regulates FOXP2 expression.
The development of nuclease mediated genome editing tools, specially, of those based on clustering regularly interspaced short palindromic repeats (CRISPR) (Sakuma and Woltjen 2014; Torres-Ruiz and Rodriguez-Perales 2016) , has emerged as a highly efficient way of inducing targeted chromosomal deletions and an accurate method to validate the functionality of enhancers (Cong et al. 2013; Mali et al. 2013 ). Here we report a detailed study of the intergenic region between the FOXP2 and MDFIC genes. We have found that this region contains, apart from the enhancer reported in Becker et al. (2015) , a second functional enhancer, FOXP2-E proximal . We performed targeted deletions of each regulatory element by CRISPR-Cas9 and found that both affect the expression levels of FOXP2 and MDFIC in an opposite manner, increasing FOXP2 and reducing MDFIC mRNA and protein levels. We hypothesise therefore that the breakpoint in this case would cause FOXP2 to be anomalously downregulated by the separation of FOXP2-distal from FOXP2, while MDFIC to be anomalously upregulated by the separation of FOXP2-proximal from MDFIC. These changes in the expression levels of these two genes may account for the observed language deficits in this case. We expect these findings contribute to a better understanding of how FOXP2 is regulated. For electroporation, we used the Neon Transfection System (Life Technologies). The manufacturer's protocols for HEK293A, SK-N-MC and SH-SY5Y cells were modified as follows. The three cell types were electroporated at 80% confluence. Cells were trypsinized and resuspended in R solution (Life Technologies). For SK-N-MC and SH-SY5Y, 10-µl tips were used to electroporate 2.510 6 cells with a single 50-ms pulse of 900 V. For HEK293A cells, 410 5 cells were electroporated with 10-µl tips using three 10-ms pulses of 1245 V. After electroporation, cells were seeded in a 24-well plate containing prewarmed medium. When required, cells were sorted 72 h post-transfection.
MATERIALS AND METHODS

Cell culture and electroporation
Construction of Double-Guide Cas9-Encoding Plasmids
The parental pLV-U6 #1 H1 #2 -C9G vector has been described elsewhere (Torres et al. 2014a) . Two gBlocks gene fragments were synthesized to clone sgRNA#1 and sgRNA#2 flanking the FOXP2-E proximal and FOXP2-E distal enhancer regions in the backbone vector using BsrGI and SpeI target sites.
Flow Cytometry and Cell Sorting 72 hours after electroporation, cells were trypsinized and washed with DPBS twice, counted, and resuspended in an appropriate volume of sorting buffer (PBS containing 1% FBS and antibiotics) for flow cytometry analysis. Immediately before cell sorting, samples were filtered through a 70-µm filter to remove any clumps or aggregates. Cell sorting was carried out in a Synergy 2L instrument (Sony Biotechnology Inc.); flow cytometry was performed in a BD LSR Fortessa analyzer (BD Biosciences). Cells were sorted and seeded individually per well in a 96 well-plate.
Genomic DNA Extraction and PCR Analysis
Genomic DNA was extracted using standard procedures (Torres et al. 2014b) . Briefly, 5-1010 6 cells were either trypsinized or scraped, washed in PBS, pelleted, and lysed in 100mM NaCl, Tris (pH 8.0) 50mM, EDTA 100mM, and 1% SDS. After overnight digestion at 56ºC with 0.5 mg/ml of proteinase K (Roche Diagnostics), the DNA was cleaned by precipitation with saturated NaCl, and the clear supernatant was precipitated with isopropanol, washed with 70% ethanol, air-dried, and resuspended overnight at room temperature in 1xTE buffer. Serial DNA dilutions were quantified with a NanoDrop ND 1000 Spectrophotometer (NanoDrop Technologies).
Standard PCR was performed in a Veriti 96-well Thermal Cycler (Applied Biosystems) under the following conditions: template denaturation at 95°C for 1 min followed by 30 cycles of denaturation at 94°C for 30 s, annealing at 62.5°C for 30 s, extension at 72°C for 60 s, and a final extension of 5 min at 72°C. Primers used are listed in Supplementary Table 1 .
RNA extraction and PCR
Total RNA was extracted from tissues and cell cultures using Trizol (Sigma-Aldrich), followed by treatment with RNase-free DNAse (Roche Applied Science). cDNA was synthesized from 500 ng of total RNA using the Superscript III First Strand cDNA Synthesis Kit (Life Technologies). Specific mRNAs were quantified by qRT-PCR using an ABI Prism 7900 HT Detection System (Applied Biosystems) and TaqMan detection. PCR was performed in 96-well plate microtest plates with TaqMan master mix (Thermo Fisher) for 40 cycles. In all experiments, mRNA amounts were normalized to the total amount of cDNA by using amplification signals for hGUSB. Each sample was determined in triplicate, and at least three independent samples were analysed for each experimental condition.
Western Blot
Proteins were extracted by standard procedures as previously described (Rodriguez-Perales et al. 2015) in the presence of Complete Protease Inhibitor Cocktail Tables (Roche Applied Science). Proteins were transferred to PVDF using TransFi (Invitrogen; Life Technologies), and membranes were probed for FOXP2 or MDFIC with monoclonal mouse anti-human FOXP2 or MDFIC antibodies (1/1000 or 1/500; BD Pharmigen) or for GAPDH (AbCam), with antibodies diluted 1/2500 in PBS/0.1% Tween-20 (PBS-T).
Secondary antibodies were HRP-conjugated with goat anti-mouse IgG (1/1000) and goat anti-Rabbit (1/500; Dako, Barcelona, Spain), and blots were developed with ECL (GE Healthcare).
Statistical Analysis
Data from three or more independent experiments were analysed by two-tailed unpaired t-test. NS, nonsignificant; * p<0.05; ** p<0.01; *** p<0.001; and **** p<0.0001.
RESULTS
In silico search of enhancer regions
We first hypothesised that the breakpoint in 7q31.1 (114,888,284 hg38) affected the expression of FOXP2 by physically separating some cis-acting distant element with an enhancer role. Accordingly, we searched in silico for putative enhancers in the intergenic region between FOXP2 and MDIFC looking for the following hallmarks: DNase I hypersensitive sites, presence of histones with specific post-translational modifications (specifically histone H3, lysine 4 monomethylation (H3K4me1) and H3 lysine 27 acetylation (H3K27ac)), and ChIP-seq data provided by ENCODE of regions recruiting co-activators and co-repressors as revealed by chromatin immunoprecipitation followed by deep sequencing. We found two putative enhancers located at 120kb and 203.5kb downstream the stop codon of FOXP2, respectively ( Figure 1A and 1B). These putative enhancers (referred as FOXP2-E proximal and FOXP2-E distal ) span 6264bp (chr7:114,817,431-114,823,694 hg38) and 2300bp (chr7:114,900,989-114,903,302 hg38 equivalent to 114,541,370-114,542,201 hg19) , respectively. FOXP2-E distal is the one previously validated by luciferase assay by Becker et al. (2015) ; FOXP2-E proximal is a new putative regulatory element.
CRISPR deletion of FOXP2-E proximal and FOXP2-E distal
We then tested in vitro the functionality of FOXP2-E proximal and FOXP2-E distal . Since both putative enhancers are located in an intergenic region, we aimed at characterizing that both of them are functional with respect to FOXP2 or/and MDFIC. We relied on a CRISPR genome editing approach to delete the entire predicted sequence of each enhancer. Accordingly, we designed two couples of sgRNAs targeting the flanking regions of either FOXP2-E proximal or FOXP2-E distal ( Figure 1C ). Each sgRNA pair was cloned in the pLV-U6 #1 H1 #2 -C9G (Torres et al. 2014b ) in order to couple the expression of the sgRNAs to the expression of Cas9 and a GFP reporter. Subsequently, we tested if the sgRNAs were able to induce the expected deletions. HEK293A cells were nucleofected with 2ug of pLV-U6 #1 H1 #2 -C9G plasmid targeting either FOXP2-E proximal or FOXP2-E distal . After 72 h, the DNA was isolated and analyzed. After designing PCR oligos that span the deleted regions ( Supplementary Table 1 ), PCR assays were performed. They revealed efficient targeted deletions of the 6.2kb or the 2.3kb regions containing the entire sequence of FOXP2-E proximal and FOXP2-E distal , respectively (data not shown). that changes produced by CRISPR-Cas9 were not due to unspecific effects. Cells were electroporated with 2ug of either pLV-U6 #1 H1 #2 -C9G-E proximal , pLV-U6 #1 H1 #2 -C9G-E distal , or with empty plasmids. After 72h the DNA was extracted and analysed. PCR and Sanger sequencing analyses confirmed the deletion of the 6.2kb or the 2.3kb fragment (Figures 2A and 2B) . We then generated two clonal cell lines (one for each putative enhancer) by sorting GFP positive cells into 96-well plates for single cell colony expansion. We confirmed by PCR that each expanded cellular clone harbours a deletion containing either the FOXP2-E proximal or the FOXP2-E distal regions (data not shown). These two cell lines were used for further expression analyses.
FOXP2 and MDFIC expression analyses
We next aimed to characterize in more detail the functionality of FOXP2-E proximal and FOXP2-E distal . We 
DISCUSSION
In this paper we have characterised in detail the role of two functional regulatory elements located downstream FOXP2. One of these enhancers, FOXP2-E distal , had been previously found to be functional in a luciferase assay (Becker et al. 2015) . We have been able to prove that if deleted, FOXP2 becomes downregulated and the levels of FOXP2 protein are reduced in the SK-N-MC neuroblastomic cell-line. We have further proved that it also affects the adjacent gene, MDFIC. Its deletion upregulates MDFIC and increases the levels of MDFIC protein. The second enhancer, FOXP2-E proximal was previously unknown.
We have found that its deletion also downregulates FOXP2 and upregulates MDFIC. These findings are coherent with previous studies reporting pairs of genes being governed by the same regulatory regions (Gould et al. 1997; Tsujimura et al. 2010) , which in some cases have proven to regulate recruitment of RNA polymerase II to promoters of both genes (Collins et al. 2012) .
FOXP2 is a well-known gene, important for speech and language Scharff 2009, Graham and Fisher 2013) . Less is known about the role of MDFIC in cognitive development and disease. There is evidence that the gene might be associated to language development and cognitive impairment (DECIPHER patients 262086, 292652, and 301696) . MDFIC is a MyoD family inhibitor domain containing protein that acts as an activator or repressor of transcription (Thebault et al. 2000 , Gautier et al. 2005 .
Similarly to FOXP2, it interacts with LEF1, as part of beta-catenin regulation (Kusano et al. 2002) . In chicken MDFIC is targeted by miR-130a (Han et al. 2016 ), known to regulate neurite outgrowth and dendritic spine density by targeting MeCP2, the main candidate for Rett syndrome, a condition involving language deficits (Zhang et al. 2016) . MDFIC is highly expressed in the cerebellum during human embryonic development and in the thalamus after birth (Human Brain Transcriptome http://hbatlas.org/). These two brain regions, interacting in a dopaminergic cortico-striato-thalamic loop, seem to play an important role in timing sensorimotor control, needed for auditory-motor language processing (Alcock et al. 2000 , Vargha-Khadem et al. 2005 . The cerebellum and thalamus of those bearing the R553H mutation in FOXP2, associated to speech and language impairment, exhibit volumetric changes of their grey matter (Watkins et al. 2002 a) . This suggests that the modulation of the size of neural populations in particular regions in the loop may impact in sensorimotor performance.
Our findings in a human neuronal cell line give support to the view that the breakpoint in our proband, which separated each of these two intergenic enhancers from each other and consequently from one of the two genes they regulate, may have altered the expression levels of both FOXP2 and MDFIC contributing to the observed speech and language deficits (Moralli et al 2015) . Whereas MDFIC remained in chromosome 7q with, predictably, FOXP2-E distal , FOXP2 was rearranged to chromosome 11p with, predictably, FOXP2-E proximal . Accordingly, we expect the expression of FOXP2 to be down-regulated and the expression of MDFIC to be up-regulated. The knockdown of FoxP2 in zebra finch results in a shorter window for song learning and in less accurate and shorter song imitation (Haesler et al., 2007) . This is coherent with the inability that those carrying the R553H mutation of FOXP2 show in repeating words and pseudowords (Watkins et al., 2002b) . Further confirmation of our hypothesis would need to be supported in a specific neuronal brain cell line grown from stem cells of the proband, as well as in songbirds in which these enhancers have been deleted.
We expect that our findings also contribute to a better understanding of the role that this region may have played in the evolution of language. Differences in the expression levels of both FOXP2 and MDFIC are expected between extinct hominins and modern humans, plausibly accounting for some of the presumed differences in their language abilities. Neanderthals bear the ancestral allele of a binding site for POU3F2 within intron 8 of FOXP2, which is more efficient in activating transcription (Maricic et al. 2013) .
Accordingly, higher levels of FOXP2 are expected in this hominin species. Likewise, the MDFIC locus is among the top five percent S score regions in modern humans (Green et al. 2010, table S37) . Finally, both genes are functionally related to RUNX2, which encodes an osteogenic factor that controls the closure of cranial sutures and several aspects of brain growth, and that has been related to the changes that brought about our more globular brain (case) and our species-specific mode of cognition, including language (Boeckx and Benítez-Burraco 2014; Benítez-Burraco and Boeckx 2015) . Further confirmation of this hypothesis would need to be supported by the analysis of the enhancers' sequences in extinct hominins and by mimicking the attested changes (if any) in a human cell line.
Ii is expected that our study, together with new available data about seed sequences of miRs in the 3'UTR region of FOXP2 (Clovis et al. 2012; Shi et al. 2013; Fu et al. 2014a; Cuiffo et al. 2014 
